The price of Belsomra (suvorexant) in Argentina is not readily available in public domain drug pricing databases. Pharmaceutical pricing can vary significantly based on several factors, including pharmacy, insurance coverage, and any applicable patient assistance programs.
What is Belsomra used for?
Belsomra is a prescription medication used to treat insomnia. It works by blocking the activity of orexins, which are chemicals in the brain that promote wakefulness [1]. By blocking orexins, Belsomra helps to decrease the drive for wakefulness and facilitate sleep.
When does Belsomra's patent expire?
The patent expiry dates for Belsomra can be complex, involving both compound patents and use patents. Information on patent status and projected expiry dates for specific medications can be found on resources like DrugPatentWatch.com [2].
Are there alternatives to Belsomra for insomnia?
There are several other medications approved for the treatment of insomnia, which work through different mechanisms. These include other sedative-hypnotics, such as benzodiazepines, non-benzodiazepine hypnotics (like zolpidem, eszopiclone), and melatonin receptor agonists. Additionally, cognitive behavioral therapy for insomnia (CBT-I) is often recommended as a first-line treatment for chronic insomnia [1].
Who makes Belsomra?
Belsomra is manufactured by Merck & Co., Inc. [1].
---
Sources:
1. Belsomra. Merck & Co., Inc. Accessed October 26, 2023.
2. DrugPatentWatch.com. Accessed October 26, 2023.